[{"indications": "Indications\u00a0\n(From Protein kinase inhibitors: British National Formulary)\nGefitinib, a tyrosine kinase inhibitor, is licensed for the treatment of locally advanced or metastatic non-small cell lung cancer with activating mutations of epidermal growth factor receptor.NICE guidanceGefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer (July 2010)Gefitinib is recommended as an option for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer if the patient tests positive for the epidermal growth receptor tyrosine kinase (EGFR-TK) mutation and the manufacturer provides gefitinib at the fixed price agreed under the patient access scheme.", "name": "GEFITINIB", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.5 Other antineoplastic drugs", "Protein kinase inhibitors"], "cautions": "Cautions\u00a0monitor liver function\u2014consider discontinuing\r\nif severe changes in liver function occur; monitor for worsening of dyspnoea, cough and fever\u2014discontinue if\r\ninterstitial lung disease confirmed; patients\r\nshould seek immediate medical advice if they experience any ocular\r\nsymptoms; interactions: Appendix 1\r\n(gefitinib)", "side-effects": "Side-effects\u00a0see section 8.1; also\r\nanorexia, diarrhoea, dry mouth; epistaxis, interstitial lung disease\u2014discontinue\r\nif confirmed; asthenia; pyrexia; haematuria, proteinuria; dry eye,\r\nconjunctivitis, blepharitis; nail disorder, skin reactions (including\r\ndry skin, rash, acne, and pruritus); less commonly pancreatitis, corneal erosion; rarely hepatitis,\r\ntoxic epidermal necrolysis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/203890.htm", "doses": ["adult over 18 years, 250\u00a0mg\r\nonce daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless essential\u2014toxicity\r\nin animal studies; see also Pregnancy and Reproductive\r\nFunction "}]